Where does Dose Medical Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Dose Medical Corporation ranks #17,614 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Dose Medical Corporation hold?

Dose Medical Corporation holds 16 US utility patents granted between 2015 and 2025, spanning 6 technology areas.

What is Dose Medical Corporation's Innovation Score?

Dose Medical Corporation has an Innovation Score of 48.7 out of 100 (top 16% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Dose Medical Corporation's patent grant rate increasing or decreasing?

Dose Medical Corporation's recent grant velocity is +17% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Dose Medical Corporation's patents?

Dose Medical Corporation's patents average 17.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Dose Medical Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Dose Medical Corporation

Q: What technology areas does Dose Medical Corporation focus on?

Dose Medical Corporation's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 14 patents, ranking #463 of 3,082 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

USPTO PatentsView assignee record - 16 granted patents across 6 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Dose ranks #17,614 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 6 technology areas.

#17,614
of 49,997 US assignees by volume: Top 16%
by Innovation Score (48.7/100): 17.1
avg claims per patent: +17%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R17614 · US Corporation #17,614 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 16 grants
MID-PACK #17,614/49,997
PHOTO-FINISH Digital ai Software
CPC-NARROW A61F · 6 areas
INNOV-PAR 48.7/100
CLAIMS-RICH 17.1 claims/avg
TYPE-USCORP US Corporation
VEL-UP +17% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Digital.ai Software, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Dose’s 48.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.8 pts (20%) Velocity 20.0 pts (41%) Breadth 8.7 pts (18%) Claim depth 10.3 pts (21%)

Qualcomm Incorporated · highest

85
Dose Medical · this assignee

49
3D Lighting… · lowest

7

What this shows Dose's Innovation Score is 48.7/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Dose?

Each dot is one of Dose’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Dose’s own 17.1 claims/patent is ABOVE the 13.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Dose vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Dose's grants concentrate

Dose Medical Corporation is a focused PatentsView assignee: 6 CPC subclasses with 87.5% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2017 (4 grants) versus a trough of 1 in 2015. By volume, Dose sits between Digital.ai Software, Inc. and Dugan Patents, LLC.

Dose's three-year grant acceleration

Dose Medical Corporation shows 6 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Digital ai Softwa…

16
Doble Engineering

16
Dongguan Littelfu…

16
Dongwoon Anatech

16
Dr Fresh

16
Drew

16
Dräger Medical

16
Dugan Patents

16
Dose Medical ◀

16

What this shows Dose holds 16 patents at rank #17,616, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Dose

By rank, the assignees closest to #17,616 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Dose's primary technology class.

Dose's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Dose Medical Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	6.3%
2017	4	25.0%
2019	1	6.3%
2020	1	6.3%
2022	4	25.0%
2024	2	12.5%
2025partial year	3	18.8%

Which technologies does Dose Medical Corporation patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 14

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 5

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

C08L - Compositions OF Macromolecular Compounds 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Dose Medical Corporation's patent record in context - here's where to go next.

Dose Medical Corporation's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 87.5% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #17,614 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Dose Medical Corporation against Digital.ai Software, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.